EirGenix is a contract development and manufacturing organization that provides high-quality and cost-effective service. We support our clients in the development, analytical testing, and cGMP manufacturing of biopharmaceuticals from pre-clinical to commercial manufacturing. EirGenix also specializes in the development of biologics, specializing in the development of biosimilars.
Our Services:
- Cell Line Development (mammalian/microbial systems)
- Process Development and Process Optimization
- Analytical Services and Quality Control
- cGMP Manufacturing (mammalian/microbial systems)
- Taiwan FDA inspected/approved
- Japan PMDA inspected/approved
- U.S. FDA inspection pending (June 2022)
- EMA inspection pending (2022-2023)
- Antibody-Drug Conjugate (ADC) Development and Manufacturing
Company Details
- Employees
- 229
- Founded
- -
- Address
- 101, Lane 169, Kangning St., Xizhi Dist,, New Taipei City,22180,taiwan, Province Of China
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- eirgenix.com
- HQ
- New Taipei City
Eirgenix, Inc. Questions
Eirgenix, Inc.'s website is eirgenix.com
Eirgenix, Inc.'s LinkedIn profile is https://tw.linkedin.com/company/eirgenix-inc
Eirgenix, Inc. has
229 employees.
View email and phone details for 229
employees at Eirgenix, Inc..
Eirgenix, Inc.'s industry is
Biotechnology Research
Eirgenix, Inc.'s top competitors are
Amaran Biotech,
Bora Pharmaceuticals,
Formosa Laboratories, Inc.,
Taiwan Bio-Manufacturing Corporation,
台康生技eirger's Inside Out,
Lumosa Therapeutics Co., Ltd.,
Obi Pharma,
Pharmaessentia,
Mycenax Biotech Inc.,
Taimed Biologics.
Eirgenix, Inc.'s categories are Biotechnology Research
Eirgenix, Inc.'s founding year is 2012
